These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15343066)

  • 21. The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice.
    Nissbrandt H; Engberg G
    J Neural Transm (Vienna); 1996; 103(11):1255-63. PubMed ID: 9013412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lesions of the lateral habenula dissociate the reward-enhancing and locomotor-stimulant effects of amphetamine.
    Gifuni AJ; Jozaghi S; Gauthier-Lamer AC; Boye SM
    Neuropharmacology; 2012 Nov; 63(6):945-57. PubMed ID: 22842070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine.
    Chiang YC; Chen PC; Chen JC
    Brain Res; 2003 May; 972(1-2):159-67. PubMed ID: 12711089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
    Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A GABA(B) agonist reverses the behavioral sensitization to morphine in rats.
    Bartoletti M; Ricci F; Gaiardi M
    Psychopharmacology (Berl); 2007 May; 192(1):79-85. PubMed ID: 17242923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates.
    Brebner K; Ahn S; Phillips AG
    Psychopharmacology (Berl); 2005 Feb; 177(4):409-17. PubMed ID: 15630589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural sensitisation to repeated d-amphetamine: effects of excitotoxic lesions of the pedunculopontine tegmental nucleus.
    Alderson HL; Faulconbridge LF; Gregory LP; Latimer MP; Winn P
    Neuroscience; 2003; 118(2):311-5. PubMed ID: 12699767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction.
    Lamarque S; Taghzouti K; Simon H
    Neuropharmacology; 2001 Jul; 41(1):118-29. PubMed ID: 11445192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated d-amphetamine enhances stimulated mesoamygdaloid dopamine transmission.
    Harmer CJ; Hitchcott PK; Morutto SL; Phillips GD
    Psychopharmacology (Berl); 1997 Aug; 132(3):247-54. PubMed ID: 9292624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
    Masserano JM; Karoum F; Wyatt RJ
    Behav Pharmacol; 1999 Jul; 10(4):429-32. PubMed ID: 10780811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
    Shen MY; Perreault ML; Fan T; George SR
    Pharmacol Biochem Behav; 2015 Jan; 128():33-40. PubMed ID: 25444866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-cycloserine inhibits the development and the expression of locomotor sensitization to amphetamine in rats.
    Gaiardi M; Colantoni A; De Luca V; Bartoletti M
    Behav Pharmacol; 2010 May; 21(3):165-70. PubMed ID: 20445441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA(B) modulation of dopamine release in the nucleus accumbens core.
    Pitman KA; Puil E; Borgland SL
    Eur J Neurosci; 2014 Nov; 40(10):3472-80. PubMed ID: 25229321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of chronic amphetamine and baclofen administration on cAMP levels and phosphorylation of CREB in distinct brain regions of wild type and monoamine oxidase B-deficient mice.
    Yin HS; Chen K; Kalpana S; Shih JC
    Synapse; 2006 Dec; 60(8):573-84. PubMed ID: 16983645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novelty response and 50 kHz ultrasonic vocalizations: Differential prediction of locomotor and affective response to amphetamine in Sprague-Dawley rats.
    Garcia EJ; Cain ME
    Psychopharmacology (Berl); 2016 Feb; 233(4):625-37. PubMed ID: 26564232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine.
    Chi H; Jang JK; Kim JH; Vezina P
    Neuropharmacology; 2006 Oct; 51(5):986-92. PubMed ID: 16901517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine.
    Zhang K; Tarazi FI; Campbell A; Baldessarini RJ
    Neuroscience; 2000; 101(1):5-10. PubMed ID: 11068131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
    Dalia A; Uretsky NJ; Wallace LJ
    Brain Res; 1998 Mar; 788(1-2):111-7. PubMed ID: 9554973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced inhibitory action of a GABAB receptor agonist on [3H]-dopamine release from rat ventral tegmental area in vitro after chronic nicotine administration.
    Amantea D; Bowery NG
    BMC Pharmacol; 2004 Oct; 4():24. PubMed ID: 15494079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.